FDA Updates Advice on Eating Fish for Pregnant Women, Children
The update does not change recommendations but puts more focus on the health benefits of fish consumption for pregnant women and children. Medscape Medical News …read more
FDA Warning Letters Drop by a Third Under Trump
Some experts say there is cause for concern. The FDA says the numbers shift year to year, that such letters are only one tool the agency uses, and the drop does not signal a change in priorities. Medscape Medical News …read more
‘Impressive’ Antitumor Effects
An experimental agent had ‘impressive’ results in metastatic, pretreated cancers, especially breast cancer, in a phase 1/2 study. Medscape Medical News …read more
Cardiovascular risk linked not to weight, but to body fat storage
Research in a large cohort of women over the age of 50 suggests that body shape, resulting from fat distribution, is associated with cardiovascular risk. …read more
Democratic Candidates Put Healthcare Front and Center at Debates
Healthcare topics took up a large portion of the first debates, with all candidates making universal health coverage a central theme of the 2 nights. Medscape Medical News …read more
How do breasts change during and after pregnancy?
Changes in the breasts are a regular occurrence during and after pregnancy. Breast changes vary from person to person and can occur whether a woman breastfeeds or not. Learn more about the types of changes and when they may signal an underlying condition. …read more
Men Ask Most Questions at Conferences, but Awareness Helps
Talking to conference attendees about the question-asking gender gap can help close it, a study has found. Medscape Medical News …read more
Testosterone Therapy Disappoints for Anorexia
Previous research pointed to testosterone as a promising intervention for anorexia, but this study shows it is no more effective than placebo. Medscape Medical News …read more
EU OKs Liraglutide in Kids; Rejects Romosozumab for Osteoporosis
The CHMP recommended approval of the GLP-1 agonist liraglutide for type 2 diabetes in children aged 10 and older, but it recommended refusal of marketing authorization for osteoporosis agent romosozumab. International Approvals …read more
Is a diabetes drug the key to aggressive breast cancer?
The blood sugar-lowering drug metformin changes how cancer stem cells use and metabolize energy, making them more vulnerable to a new treatment. …read more